ThermoGenesis Holdings, Inc. (THMO)
| Market Cap | 1.59K |
| Revenue (ttm) | 9.61M |
| Net Income (ttm) | -14.75M |
| Shares Out | 15.85M |
| EPS (ttm) | -4.82 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 644 |
| Average Volume | 3,919 |
| Open | 0.0001 |
| Previous Close | n/a |
| Day's Range | 0.0001 - 0.0001 |
| 52-Week Range | 0.0000 - 0.0100 |
| Beta | 13.08 |
| RSI | 37.54 |
| Earnings Date | Aug 8, 2025 |
About ThermoGenesis Holdings
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separation System, an automated fully closed cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automat... [Read more]
Financial Performance
In 2023, ThermoGenesis Holdings's revenue was $9.45 million, a decrease of -9.90% compared to the previous year's $10.48 million. Losses were -$17.98 million, 59.5% more than in 2022.
Financial StatementsNews
Global Biopreservation Market Set to Surpass USD 7.1 Billion by 2029 | MarketsandMarkets™
Delray Beach, FL,, Oct. 08, 2025 (GLOBE NEWSWIRE) -- formation, and contamination risks threaten sample viability. Ensuring consistent global transportation standards will be a key differentiator for ...
The Ice Water Hack: How Aqua Sculpt Boosts Thermogenesis for Fat Loss
AURORA, Colo., March 10, 2025 (GLOBE NEWSWIRE) -- Losing weight can often feel like an uphill battle, with conflicting advice and complicated diets making the process overwhelming. However, a simple y...
Ice Water Hack: How Aqua Sculpt Improves Thermogenesis for Weight Loss
AURORA, Colo., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Ice Water Hack stands at the core of a rapidly rising weight-loss phenomenon that, according to Dr. Blaine—a leading advocate of metabolic research—rev...
ThermoGenesis Holdings, Inc. (THMO) Q3 2023 Earnings Call Transcript
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications, IR Dr. Chris Xu - Chief Executive Off...
ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update
Conference Call to be Held on November 13, 2023 RANCHO CORDOVA, Calif. , Nov. 8, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools an...
ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento
An ISO 7 cGMP Cleanroom Facility Grand Opening On October 26, 2023 RANCHO CORDOVA, Calif. , Oct. 26, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell...
ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference
RANCHO CORDOVA, Calif. , Sept. 6, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, ...
Thermogenesis Holdings, Inc. (THMO) Q2 2023 Earnings Call Transcript
Thermogenesis Holdings, Inc. (NASDAQ:THMO) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Paula Schwartz - IR, Rx Communications Group Chris Xu - CEO Jeff Cauble - C...
ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update
Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update
Conference Call to be Held on August 10, 2023 RANCHO CORDOVA, Calif. , Aug. 8, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and ...
ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu
RANCHO CORDOVA, Calif. , July 17, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, ...
ThermoGenesis Holdings, Inc. (THMO) Q1 2023 Earnings Call Transcript
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications Chris Xu - Chief Executive Officer Jeff Cau...
ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate Update
Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.
ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic Update
Conference Call to be Held on May 15, 2023 RANCHO CORDOVA, Calif. , May 10, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and ser...
ThermoGenesis Holdings, Inc. (THMO) Q4 2022 Earnings Call Transcript
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications Chris Xu - Chief Executive Officer Jeff C...
ThermoGenesis Holdings Announces Year End 2022 Financial Results and Provides Corporate Update
Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m.
ThermoGenesis Holdings to Announce Financial Results for the Year Ended December 31, 2022 and Provide a Corporate Strategic Update
Conference Call to be Held on March 30, 2023 RANCHO CORDOVA, Calif. , March 28, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing and point...
THERMOGENESIS CLOSES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES
RANCHO CORDOVA, Calif. , March 20, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field,...
THERMOGENESIS ANNOUNCES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES
RANCHO CORDOVA, Calif. , March 16, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field,...
Why ThermoGenesis Stock Is Soaring Wednesday
ThermoGenesis said it plans to rent out its current Good Manufacturing Practices suites in the second and third quarters. The company was nearly delisted from the Nasdaq last year.
ThermoGenesis Announces Roll Out of ReadyStart cGMP Suites for Early-Stage Cell and Gene Therapy Companies
RANCHO CORDOVA, Calif. , March 15, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field,...
ThermoGenesis Regains Compliance with Nasdaq Minimum Bid Price Requirement
RANCHO CORDOVA, Calif. , Jan. 11, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (NASDAQ: THMO) (the "Company"), a market leader in automated cell processing and point-of-care, autologous cell-base...
ThermoGenesis Announces 1-for-45 Reverse Stock Split
RANCHO CORDOVA, Calif. , Dec. 21, 2022 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (NASDAQ: THMO) (the "Company"), a market leader in automated cell processing and point-of-care, autologous cell-base...
ThermoGenesis Holdings, Inc. (THMO) CEO Dr. Chris Xu on Q3 2022 Results - Earnings Call Transcript
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Paula Schwartz - Rx Communications Dr. Chris Xu - Chief Executive Officer...